Back
TNF-α Antagonist and Infection in Rheumatoid Arthritis
Julia F. Simard, Murray A. Mittleman, Nancy A. Shadick, Elizabeth W. Karlson
Open J. Rheumatol. Autoimmune Dis. Vol.2 No.2, May 07, 2012  DOI: 10.4236/ojra.2012.22004
       (PDF  266K)     HTML     
Effect of Anti-TNF Therapy on Resistance to Insulin in Patients with Rheumatoid Arthritis
Mario Pérez, Raul Ariza, Ruben Asencio, Adolfo Camargo, Heladia Garcia, Miguel Angel Vazquez, Leonor Barile-Fabris
Open J. Rheumatol. Autoimmune Dis. Vol.3 No.3, August 16, 2013  DOI: 10.4236/ojra.2013.33026
       (PDF  147K)     HTML     
Biological Therapy and Risk of Malignancies: A Literature Review
Gilda Sandri, Valentina Cestelli, Maria Teresa Mascia
J. Cancer Ther. Vol.4 No.3, March 18, 2013  DOI: 10.4236/jct.2013.43A056
       (PDF  144K)     HTML     
Comparative Clinical Trial of Antibodies to Interferon-Gamma (IFN-γ) and Tumor Necrosis Factor-Alpha (TNF-α) in the Treatment of Rheumatoid Arthritis
Simon Skurkovich, Galina Lukina, Yakov Sigidin, Olga Pushkova, Evelyna Mach, Boris Skurkovich
J. Immune Based Ther.Vaccines Antimicrob. Vol.4 No.1, January 19, 2015  DOI: 10.4236/jibtva.2015.41001
       (PDF  2649K)     HTML      XML
Antibodies to Tumor Necrosis Factors in the Treatment of Rheumatoid Arthritis and Spondyloarthritis: The Basic Science, Clinical Science and Unmet Needs; Results from a Single Center
Sundeep Kumar Upadhyaya
Open J. Rheumatol. Autoimmune Dis. Vol.4 No.2, May 04, 2014  DOI: 10.4236/ojra.2014.42013
       (PDF  261K)     HTML      XML
 
 
Top